Skip to Content

  • Search

View Additional Section Content

ECOG E2905 - Randomized Phase III Trial Comparing the Frequency of Major Erythroid Response (MER) to Treatment with Lenalidomide (Revlimid(r)) Alone and in Combination with Epoeitn Alfa (Procrit(r)) in Subjects with Low- or Intermediate-1 Risk MDS and Symptomatic Anemia.

For more information on this trial, click the link below.

https://clinicaltrials.gov/ct2/show/study/NCT00843882?term=ecog+2905&rank=1

Clinical Trial Categories

  • Myleodysplastic Syndrome
Contact
The Rosenfeld Cancer Center at 215-481-2402

Location

  • The Rosenfeld Cancer Center

Find a Physician
Search Our Directory

215-481-MEDI

Schedule a
Test

215-481-EXAM

Clinical Trials Details